We wish to congratulate the authors on their publication "Acute urinary retention: how useful is an ambulatory care protocol?" [Hong Kong J Emerg Med 2009; 16(3):134-140] . We would like to make comments concerning two issues in the study.
From Table 3 , we saw that the minimum urine volume on first catheterization was only 20 ml. For cases with minimal volume collected, we doubt whether they were genuine acute urinary retention, or in fact lower urinary tract symptom or anuria. With minimal volume on first catheterization, the patient probably did not need urinary catheterization. We therefore wonder whether those cases should be included in the evaluation of predictors for successful trial without catheterization (TWOC) for acute urinary retention (AUR). This could have an effect on drawing the conclusion that "urine volume of less than 700 ml on first catheterization was associated with a higher success of TWOC" for AUR.
We were also interested in the potential predictors for successful TWOC listed in Table 2 . When we looked at "BPH on α-blocker", the frequency was 86 out of 143 valid samples. Therefore subjects who were not on α-blocker should be 143-86=57 for dichotomous variable. When we looked at "α-blocker initiation", the listed valid sample was 143 and frequency was 24. Conceptually, patients with "α-blocker initiation" should be the ones who were not on α-blockers before. Therefore, it is curious that the listed valid sample of "α-blocker initiation" was "143" instead of "57" as we might suppose. In other words, "α-blocker initiation" might not be suitable for use as dichotomous variable if performed in the study's fashion. Otherwise, this may pose a problem when the predictor was put into binary logistic regression calculation.
The supposed patient characteristics from the article may be as follows: For the first issue, it is related to our definition of acute urinary retention (AUR). In our study, AUR is defined as the sudden and painful inability to void voluntarily with the relief of symptoms following catheterization. This definition was also used in other studies on AUR. The volume of residual urine was not well defined in past studies. For you information, only 3 patients had first catheterization urine volume below 150 ml among our 143 studied patients. After we have excluded these 3 patients, the results of our study including the cut off value of 700 ml remain unchanged.
For the second issue, I agree with the point raised by Drs. Cheung and Tsui. Actually, Table 2 may be misleading. It only pointed out the valid sample of 143 (i.e. there were only 24 patients out of the 143 valid sample with alpha-blocker initiation). When we put data into the logistic regression model, 86 patients who had already been taking alpha-blocker on presentation were counted as not applicable. There would be 24 patients with alpha-blocker initiation and 33 patients without (total patients were 57 instead of 143).
